Page 45 - AN-2-3

Advanced Neurology Multiple sclerosis: Immunopathogenesis

84. Lee DH, Peschke M, Utz KS, et al., 2019, Diagnostic value 92. Alba-Arbalat S, Andorra M, Sanchez-Dalmau B, et al., 2021,
of the 2017 McDonald criteria in patients with a first In vivo molecular changes in the retina of patients with
demyelinating event suggestive of relapsing-remitting multiple sclerosis. Invest Ophthalmol Vis Sci, 62: 11.
multiple sclerosis. Eur J Neurol, 26: 540–545.
https://doi.org/10.1167/iovs.62.6.11
https://doi.org/10.1111/ene.13853
93. Vural G, Gümüşyayla Ş, Deniz O, et al., 2019, Relationship
85. Koch-Henriksen N, Thygesen LC, Stenager E, et al., 2018, between thiol-disulphide homeostasis and visual evoked
Incidence of MS has increased markedly over six decades potentials in patients with multiple sclerosis. Neurol Sci,
in Denmark particularly with late onset and in women. 40: 385–391.
Neurology, 90: e1954–e1963.
https://doi.org/10.1007/s10072-018-3660-3
https://doi.org/10.1212/WNL.0000000000005612
94. Sadam H, Pihlak A, Jaago M, et al., 2021, Identification of
86. Petersen ER, Søndergaard HB, Laursen JH, et al., 2019, two highly antigenic epitope markers predicting multiple
Smoking is associated with increased disease activity during sclerosis in optic neuritis patients. EBioMedicine, 64: 103211.
natalizumab treatment in multiple sclerosis. Mult Scler, https://doi.org/10.1016/j.ebiom.2021.103211
25: 1298–1305.
95. Gharagozloo M, Smith MD, Jin J, et al., 2021, Complement
https://doi.org/10.1177/1352458518791753
component 3 from astrocytes mediates retinal ganglion
87. Solomon AJ, Marrie RA, Viswanathan S, et al., 2023, Global cell loss during neuroinflammation. Acta Neuropathol,
barriers to the diagnosis of multiple sclerosis: Data from the 142: 899–915.
multiple sclerosis international federation atlas of MS, third https://doi.org/10.1007/s00401-021-02366-4
edition. Neurology, 101: e624–e635.
96. Liddelow SA, Guttenplan KA, Clarke LE, et al., 2017,
https://doi.org/10.1212/WNL.0000000000207481
Neurotoxic reactive astrocytes are induced by activated
88. Chun BY, Kim JH, Jung YK, et al., 2021, Protective role of microglia. Nature, 541: 481–487.
limitrin in experimental autoimmune optic neuritis. Invest https://doi.org/10.1038/nature21029
Ophthalmol Vis Sci, 62: 8.
97. Roostaei T, Sadaghiani S, Mashhadi R, et al., 2019,
https://doi.org/10.1167/iovs.62.9.8
Convergent effects of a functional C3 variant on brain
89. Winter A, Chwalisz B, 2020, MRI characteristics of NMO, atrophy, demyelination, and cognitive impairment in
MOG and MS related optic neuritis. Semin Ophthalmol, multiple sclerosis. Mult Scler, 25: 532–540.0
35: 333–342.
https://doi.org/10.1177/1352458518760715
https://doi.org/10.1080/08820538.2020.1866027
98. Jin J, Smith MD, Kersbergen CJ, et al., 2019, Glial pathology
90. Çoban A, Düzel B, Tüzün E, et al., 2017, Investigation of the and retinal neurotoxicity in the anterior visual pathway
prognostic value of adipokines in multiple sclerosis. Mult in experimental autoimmune encephalomyelitis. Acta
Scler Relat Disord, 15: 11–14. Neuropathol Commun, 7: 125.
https://doi.org/10.1016/j.msard.2017.04.006 https://doi.org/10.1186/s40478-019-0767-6
91. Pulido-Valdeolivas I, Andorrà M, Gómez-Andrés D, et al., 99. Wu Q, Miao X, Zhang J, et al., 2021, Astrocytic YAP protects
2020, Retinal and brain damage during multiple sclerosis the optic nerve and retina in an experimental autoimmune
course: Inflammatory activity is a key factor in the first encephalomyelitis model through TGF-β signaling.
5 years. Sci Rep, 10: 13333. Theranostics, 11: 8480–8499.
https://doi.org/10.1038/s41598-020-70255-z https://doi.org/10.7150/thno.60031

Volume 2 Issue 3 (2023) 14 https://doi.org/10.36922/an.1319